Viemed Healthcare (VMD) EBIT Growth (1y) (2019 - 2026)
Viemed Healthcare (VMD) EBIT Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -20.56% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 11.83% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 30.43% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 19.54% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 20.97% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 90.95% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 74.18% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -18.12% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Viemed Healthcare | 448.46 Mn | 440.63 Mn | 42.83 Mn | 11.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.85% |
| Dec 31, 2025 | 29.74% |
| Sep 30, 2025 | 0.25% |
| Jun 30, 2025 | 40.90% |
| Mar 31, 2025 | 74.27% |
| Dec 31, 2024 | 21.99% |
| Sep 30, 2024 | 33.81% |
| Jun 30, 2024 | 24.65% |
| Mar 31, 2024 | 13.96% |
| Dec 31, 2023 | 49.66% |
| Sep 30, 2023 | 186.32% |
| Jun 30, 2023 | 189.81% |
| Mar 31, 2023 | -13.97% |
| Dec 31, 2022 | -24.24% |
| Sep 30, 2022 | -49.67% |
| Jun 30, 2022 | -62.42% |
| Mar 31, 2022 | 68.77% |
| Dec 31, 2021 | -11.43% |
| Sep 30, 2021 | -27.75% |
| Jun 30, 2021 | -79.28% |